• Title/Summary/Keyword: 악하선 종양

Search Result 150, Processing Time 0.023 seconds

What's New in Molecular Targeted Therapies for Thyroid Cancer? (갑상선암 표적치료의 최신지견)

  • Min, Seonyoung;Kang, Hyunseok
    • Korean Journal of Head & Neck Oncology
    • /
    • v.37 no.2
    • /
    • pp.1-9
    • /
    • 2021
  • Thyroid cancer refers to various cancers arising from thyroid gland. Differentiated thyroid cancers (DTCs) include papillary, follicular, and Hurthle cell carcinomas and represent cancers retain normal thyroid functions such as iodine uptake. Radioactive iodine (RAI) is generally used for upfront treatment of metastatic DTCs, but RAI refractory DTCs remain to be clinical challenges. Sorafenib and lenvatinib were approved for the treatment of RAI refractory DTCs and more recently, genomics-based targeted therapies have been developed for NTRK and RET gene fusion-positive DTCs. Poorly differentiated and anaplastic thyroid cancers (ATCs) are extremely challenging diseases with aggressive courses. BRAF/MEK inhibition has been proven to be highly effective in BRAF V600E mutation-positive ATCs and immune checkpoint inhibitors have shown promising activities. Medullary thyroid cancers, which arise from parafollicular cells of thyroid, represent a unique subset of thyroid cancer and mainly driven by RET mutation. In addition to vandetanib and cabozantinib, highly specific RET inhibitors such as selpercatinib and pralsetinib have demonstrated impressive activity and are in clinical use.

A Treatment Outcomes and Prognostic Factors of Malignant Submandibular Gland Tumor (악하선 암의 치료성적과 예후인자)

  • Lim Chi-Young;Nam Kee-Hyun;Lee Jan-Dee;Chang Hang-Seok;Chung Woong-Youn;Cha In-Ho;Lee Chang-Geol;Choi Eun-Chan;Park Cheong-Soo
    • Korean Journal of Head & Neck Oncology
    • /
    • v.21 no.2
    • /
    • pp.201-207
    • /
    • 2005
  • Purpose: Submandibular gland tumor is rare, less than 6% of head and neck tumor. The purpose of this article is to analysis the clinical experience and treatment outcomes of malignant submandibular gland tumor, suggesting a guideline of management. Methods: We retrospectively evaluated 26 patients who underwent operation for malignant submandibular gland tumor at Severence hospital between 1986 and 2004. Statistical analysis was performed by Kaplan-Meier method, log rank test, Chi-square test, Fisher's exact test using SPSS v12.0 for Windows. Results: They consisted of 18 males and 8 females whose median age was 47 years(range: 20-71). 10 cases of adenocystic carcinoma, 8 cases of carcinoma ex pleomorphic adenoma, 4 cases of mucoepidermoid carcinoma, 1 case each for acinic cell carcinoma, undifferentiated carcinoma, adeno carcinoma, epithelioid hemangioendothelioma. Sialoadenectomy only was performed in 10 cases(36.5%) and sialoadenectomy with neck node dissection was performed in 16 cases(63.5%). Adjuvant radiotherapy was done in 22 cases(84.6%). 10 year disease free survival rate for malignant submandibular gland tumor was 63.1 % and 10 year overall survival rate for malignant submandibular gland tumor was 70.1%. In univariate analysis, prognostic factors affecting recurrence of malignant submandibular gland tumor was initially papable lateral neck node in physical examination and metastasis of lateral neck node in pathologic confirmation. The prognostic factors affecting survival of malignant submandibular gland tumor was tumor size, TNM stage, recurrence and type of recurrence. Conclusion: In this study, prognostic factors affecting recurrence of malignant submandibular gland tumor was initially papable lateral neck node in physical examination and metastasis of lateral neck node in pathologic confirmation. The prognostic factors affecting survival of malignant submandibular gland tumor was tumor size, TNM stage, recurrence and type of recurrence. To prevent recurrence and to improve survival, early diagnosis and aggressive surgery must be considered.

Basaloid Squamous Carcinoma of Unusual Sites (생소한 위치에 발생한 기저양 편평세포암종)

  • Cho Yong-Mee;Kim Kyu-Rae;Ro Jae-Y.;Jang Se-J.;Kim Sang-Yoon;Cho Kyung-Ja
    • Korean Journal of Head & Neck Oncology
    • /
    • v.20 no.2
    • /
    • pp.189-193
    • /
    • 2004
  • Basaloid squamous carcinoma (BSC) is an uncommon aggressive variant of squamous cell carcinoma with a predilection for hypopharynx, tongue base, and larynx. We present 5 cases of BSC of unusual sites, each from maxillary sinus, external auditory canal, submandibular gland, tonsil, and nasopharynx. Only a few cases arising in these sites have been reported to date. Patients included 3 men and 2 women with the age range of 45-69 years (mean, 56.4 years). Microscopically, the tumors were characterized by solid lobules and nests of ovoid basaloid cells with abundant desmoplastic stroma. Comedonecrosis, peripheral palisading of tumor cells, trabecular pattern, and rosette-like arrangement were commonly observed. Tumor cells had scanty cytoplasm and their nuclei were ovoid, relatively uniform, and hyperchromatic. In two cases, concomitant squamous cell carcinoma in situ was identified. Immunohistochemical stains revealed that tumor cells were strongly positive for pancytokeratin and negative or weakly positive for p63. Being aware of BSC that can arise from unusual sites would help diagnose correctly and treat properly this rare and distinct clinicopathologic entity.

EXPERIENCE WITH 6 LATISSIMUS DORSI MYOCUTANEOUS FLAPS ON HEAD AND NECK AREA RECONSTRUCTION (두경부 영역의 종양 절세후 광배근피판을 이용한 재건술)

  • Lee, Jong-Ho;Park, Kwang;Seo, Ku-Jong;Park, Ki-Deog
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • v.14 no.1_2
    • /
    • pp.105-116
    • /
    • 1992
  • Latissimus dorsi myocutaneous flap is useful for the breast reconstruction, chest wall coverage, free flap transfer, and head and neck area reconstruction, especially in large defect. We have had some experience of 5-pedicled and 1-free latissimus dorsi myocutaneous flap in head and neck area and found many advantages and some problems. The conclusions were as follows : 1. Potentially large flap size enabled us agressive tumor resection and reconstruction. 2. Speedy and easy flap elevation and long vascular pedicles reduced operation time and flap failure. 3. Due to fewer complication and functional loss of doner site, pedicled latissimus dorsi flap was a good choice for large head and neck reconstruction. 4. Because of flap bulkness, thin and small defect was not appropriate for reconstruction.

  • PDF

ODONTOGENIC GHOST CELL CARCINOMA ARISING FROM ODONTOGENIC EPITHELIAL TUMOR IN MAXILLA - A CASE REPORT (치성상피종양으로부터 상악에 발생한 치성유령세포암종의 치험례)

  • Kim, Jin-Hak;Kim, Moon-Key;Cha, In-Ho;Kim, Jin;Kim, Hyun-Sil;Choi, Hee-Soo;Kim, Hyung-Jun
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • v.30 no.3
    • /
    • pp.218-222
    • /
    • 2004
  • The neoplastic variant of calcifying odontogenic cyst has various designation, and its malignant counterpart has been reported as aggressive epithelial ghost cell tumor or odontogenic ghost cell carcinoma. Odontogenic ghost cell carcinoma(OGCC) is a rare carcinoma first documented in 1985. It is composed of varying sized islands of anucleated cells with homogenous, pale eosinophilic cytoplasm, so called ghost cells, were admixed with nucleated cells. We report a case of maxillary OGCC developed from odontogenic epithelial tumor in a 25-year-old man with literature review.

FIBRIN SEALANTS IN MAXILLOFACIAL SURGERY : A INTRODUCTORY REPORT (악안면 외과 영역에서의 FIBRIN SEALANTS 의 이용)

  • Kim, Myung-Jin;Park, Hyung-Kook
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • v.13 no.2
    • /
    • pp.129-136
    • /
    • 1991
  • The fibrin sealant was first designed as an alternative to surgical suture for the purpose of surface-to-surface union especially in parenchymal organs like the liver, spleen and kidney. The clinical application of currently used fibrin sealant was first introduced in 1972. The fibrin sealant consists of principal two components; lyophilized human fibrinogen and bovine thrombin. The fibrinogen component also contains coagulation factor XIII. A solution of aprotinin, an inhibitor of fibrinolysis is used to dissolve the fibrinogen and to provide the first component, and a solution of calcium chloride is also used to provide the second component. From July to December in 1990, during 6 months, we used fibrin sealant in the 28 patients of 33 various cases, in the following ways; supportive application of fibrin sealant after free autogenouse nerve graft for the repair of inferior alveolar nerve, facial nerve or accessory nerve, treament of hemangioma or lymphangioma to thrombosize and lead to the tumor shrinking, skin grafting to stimulate the adhesion and tissue repair, bone grafting in the patients of cleft alveolus, mandibular reconstruction or orthognathic surgery to facilitate the knitting of bone chips, tissue adhesion after tumor resection, radical neck dissection or flap reconstructions, and supportive adhesion of external auditory cannal after TMJ surgery via postauricular approach. No adverse effects were observed, none of the patients developed hepatitis or other blood transmitted disease, and the wound healing were acceptable.

  • PDF

Non Hodgkin lymphoma in the maxillary sinus mimicking dental abscess: a case report (치성 농양과 유사한 상악동에 발생한 비호지킨 림프종의 증례 보고)

  • Song, Ji-Young
    • Journal of Dental Rehabilitation and Applied Science
    • /
    • v.32 no.2
    • /
    • pp.130-134
    • /
    • 2016
  • Malignant lymphomas are neoplasms with diffuse proliferation of neoplastic lymphocytes and their precursor cells. Diffuse large B-cell lymphoma, which is a subtype of non-Hodgkin's lymphomas, rarely occurs in the head and neck area and is especially rare in the maxillary sinus. We report a case of a 76-year-old female patient who was referred to the oral and maxillofacial surgery office for evaluation of a dental abscess as a clinical diagnosis. Laboratory tests revealed no signs of inflammation or infection; therefore, incisional biopsy was performed. The final diagnosis was diffuse large B-cell lymphoma in the maxillary sinus. Here we describe this case with a review of relevant literature.

ORAL GRANULAR CELL TUMOR OF THE PALATE (구개에 발생한 과립세포종)

  • Noh, Kwang-Seob;Hong, Jong-Rak
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • v.31 no.2
    • /
    • pp.183-187
    • /
    • 2005
  • Granular cell tumor is a uncommon disease, although head and neck region accounts for approximately 50% of all lesions, 70% are located in oral cavity but can occur at other site of the body. Clinically, it usually presents as a small, slow growing, non-tender, single benign lesion but mutifocal and malignant forms are rarely encountered. The histogenic origin of this tumor was controversial for many years but recent studies using immunohistochemical study support its origin being from neural cell, probably Schwann's cell. In this report, we present a case of benign granular cell tumor occurred on the hard palate studied by histologic and immunohistochemical assay, with review of literatures.

Conservative therapy of extensive unicystic ameloblastoma: a case report (낭종성 법랑아 세포종의 치험례: 증례 보고)

  • Hyun, Chang Lim;Song, Ji-Young
    • Journal of Dental Rehabilitation and Applied Science
    • /
    • v.34 no.3
    • /
    • pp.246-250
    • /
    • 2018
  • Ameloblastoma is a benign neoplasm originating from odontogenic epithelium. It is the most common neoplasm in the jaws and is characterized by aggressive behavior and local invasion. Unicystic ameloblastoma (UA) has a unilocular feature in radiologic examination and a cystic feature histologically. Decompression and marsupialization are conservative method of treatment of large UA. The purpose of decompression and marsupialization are size reduction of the mass, which makes it easy to handle at total enucleation with protection of nerve damage and facial deformity. Here we report successful conservative treatment of extensive UA using decompression and marsupialization with a review of literatures.

A STUDY ON MUTATIONS OF P53 TUMOR SUPPRESSOR GENE IN ORAL TUMORS (구강종양에서 p53 종양억제 유전자의 돌연변이에 관한 연구)

  • Joo, Seong-Chai;Pyo, Sung-Woon
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • v.26 no.1
    • /
    • pp.45-52
    • /
    • 2000
  • Nowadays, there are a lot of evidence that mutation of the p53 tumor suppressor gene is one of the most common genetic abnormalities in neoplastic progression. In this study, we analyzed 20 specimens of oral tumors(squamous cell carcinoma 14 cases, ameloblastoma 3 cases, adenoid cystic carcinoma 2 cases, malignant schwannoma 1 case)using polymerase chain reaction and direct sequencing which used an automated DNA sequencer and software for detection of mutations. Polymerase chain reactions were performed with 4 sets of primers encompassing exon 5, 6, 7, 8, and direct sequencing method was employed. The results were as followings. 1. We detected 10 point mutations out of 20 specimens (50%). 2. The genetic alterations included 7 mis-sense mutations resulting in single amino acid subtitutions, 2 silent mutations, 1 non-sense mutations encoding a stop codon. 3. Mutations were mostly in exon 7(7 out of 10 mutations, 70%) and involved codons 225, 234, 235, 236, 238, 247. 4. Therse were 4 cases of $T{\rightarrow}A$ transversion, 2 cases of $C{\rightarrow}A$ transversion, $A{\rightarrow}G$ transition, 1 case of $C{\rightarrow}G$, $T{\rightarrow}G$ transversion respectively. 5. We could find out point mutations more conveniently using PCR - Automated Direct Sequencing method.

  • PDF